GENEGENETIC TECHNOLOGIES LTD

Nasdaq genetype.com


$ 0.91 $ 0.02 (2.02 %)    

Wednesday, 17-Jul-2024 15:57:28 EDT
QQQ $ 482.32 $ -6.33 (-1.3 %)
DIA $ 412.29 $ 3.28 (0.8 %)
SPY $ 557.05 $ -7.81 (-1.38 %)
TLT $ 94.21 $ 0.04 (0.04 %)
GLD $ 227.29 $ -1.00 (-0.44 %)
$ 0.892
$ 0.91
$ 0.00 x 0
$ 0.00 x 0
$ 0.91 - $ 0.91
$ 0.75 - $ 23.65
59,901
na
686,344
$ 1.35
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 genetic-technologies-appoints-mark-ziirsen-as-chief-financial-officer

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetype-announces-the-introduction-of-suite-of-genetic-risk-assessment-tests-to-canada-and-new-zealand

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetic-technologies-reported-monday-genetype-identifies-795-of-people-tested-in-us-australia-are-at-risk-of-serious-disease

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 genetype-stayhealthy-announce-landmark-distribution-agreement-for-multi-risk-test-to-a-broader-audience-in-the-online-pharmacy-channel-across-north-america

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...

 gtg-launches-genetype-a-novel-comprehensive-risk-assessment-test-that-covers-100-of-women-at-risk-of-developing-breast-and-ovarian-cancer

Genetic Technologies Limited ((ASX: GTG, NASDAQ:GENE, "Company", "GTG")), a global leader in genomics-based tes...